Who Paid My Doc
NHancer Rx
Device Cardiology/Vascular Diseases
PDI 08718481740231
General payments
$82,449
Research payments
$0
Through program year 2025, $82,449 in general payments and $0 in research payments were reported against NHancer Rx (Cardiology/Vascular Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $10,149 | 63 |
| 2024 | General | $33,097 | 204 |
| 2023 | General | $39,203 | 172 |
Breakdown
The top 5 of 57 recipients; each share is of general payments naming this product in 2025.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 18 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
439 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.